U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07690800) titled 'Outcomes of Intravitreal Ranibizumab Injection for Diabetic Vitreous Hemorrhage' on July 02.
Brief Summary: This prospective interventional cohort study evaluates the outcomes of intravitreal ranibizumab injection in patients with diabetic vitreous hemorrhage secondary to proliferative diabetic retinopathy. The study aims to assess the effectiveness of ranibizumab in improving visual acuity, promoting vitreous hemorrhage clearance, reducing the need for pars plana vitrectomy, and evaluating treatment-related safety.
Eligible adult patients with diabetic vitreous hemorrhage will receive intravitreal ranibizumab according to the study...